Synergy Pharmaceuticals Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: New York NY United States (2005)
Status: Acquired by Bausch Health Companies (2019)

Organization Overview

First Clinical Trial
2010
NCT01053962
First Marketed Drug
2017
plecanatide (trulance)
First NDA Approval
2017
plecanatide (trulance)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | Synergy Pharmaceuticals Inc. | Synergy Pharmaceuticals Pte. Ltd. | SYNERGY PHARMS